ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,1/9,10/10899,0.008230407058799183,0.09370329183022416,0.060859920785587926,FOXO4,1
R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/9,11/10899,0.009050126623173615,0.09370329183022416,0.060859920785587926,FOXO4,1
R-HSA-4641265,Repression of WNT target genes,1/9,12/10899,0.009869243895435864,0.09370329183022416,0.060859920785587926,CTBP2,1
R-HSA-1614558,Degradation of cysteine and homocysteine,1/9,14/10899,0.011505673112431003,0.09370329183022416,0.060859920785587926,TXN2,1
R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/9,16/10899,0.013139697805263362,0.09370329183022416,0.060859920785587926,FOXO4,1
R-HSA-4655427,SUMOylation of DNA methylation proteins,1/9,17/10899,0.013955809421522747,0.09370329183022416,0.060859920785587926,PCGF2,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/9,17/10899,0.013955809421522747,0.09370329183022416,0.060859920785587926,FOXO4,1
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/9,25/10899,0.020463135762611273,0.10122645058381563,0.06574618290998105,FOXO4,1
R-HSA-114508,Effects of PIP2 hydrolysis,1/9,27/10899,0.02208399075192391,0.10122645058381563,0.06574618290998105,ABHD6,1
R-HSA-1614635,Sulfur amino acid metabolism,1/9,28/10899,0.02289352387216237,0.10122645058381563,0.06574618290998105,TXN2,1
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1/9,29/10899,0.023702461254661578,0.10122645058381563,0.06574618290998105,FOXO4,1
R-HSA-4791275,Signaling by WNT in cancer,1/9,34/10899,0.027738225521052762,0.10122645058381563,0.06574618290998105,CTBP2,1
R-HSA-8953750,Transcriptional Regulation by E2F6,1/9,35/10899,0.02854359652614402,0.10122645058381563,0.06574618290998105,PCGF2,1
R-HSA-3299685,Detoxification of Reactive Oxygen Species,1/9,37/10899,0.03015255974837061,0.10122645058381563,0.06574618290998105,TXN2,1
R-HSA-3899300,SUMOylation of transcription cofactors,1/9,45/10899,0.03656475144496196,0.10550642750693914,0.06852601114672421,PCGF2,1
R-HSA-8854214,TBC/RABGAPs,1/9,46/10899,0.03736361981026404,0.10550642750693914,0.06852601114672421,GABARAP,1
R-HSA-4570464,SUMOylation of RNA binding proteins,1/9,47/10899,0.03816189931102054,0.10550642750693914,0.06852601114672421,PCGF2,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,2/9,433/10899,0.047111951150847056,0.12301453911610065,0.07989746101605644,CTBP2/FOXO4,2
R-HSA-9614085,FOXO-mediated transcription,1/9,65/10899,0.05243066649164474,0.1263653010375204,0.08207376775113308,FOXO4,1
R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,1/9,69/10899,0.055575832171131045,0.1263653010375204,0.08207376775113308,CTBP2,1
R-HSA-4551638,SUMOylation of chromatin organization proteins,1/9,71/10899,0.057144932422366956,0.1263653010375204,0.08207376775113308,PCGF2,1
R-HSA-9659379,Sensory processing of sound,1/9,76/10899,0.061057549555479484,0.1263653010375204,0.08207376775113308,CTBP2,1
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,1/9,77/10899,0.06183833880559508,0.1263653010375204,0.08207376775113308,PCGF2,1
R-HSA-195253,Degradation of beta-catenin by the destruction complex,1/9,83/10899,0.06651096644742482,0.13025064262620695,0.08459728188488246,CTBP2,1
R-HSA-877300,Interferon gamma signaling,1/9,92/10899,0.07348112387290495,0.1381445128810613,0.0897243196763892,TRIM8,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/9,104/10899,0.08270269095375282,0.1495010182625532,0.09710032541128875,FOXO4,1
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,1/9,121/10899,0.09562691849973248,0.15865058227374337,0.10304293137600355,PCGF2,1
R-HSA-5619507,Activation of HOX genes during differentiation,1/9,121/10899,0.09562691849973248,0.15865058227374337,0.10304293137600355,PCGF2,1
R-HSA-9007101,Rab regulation of trafficking,1/9,124/10899,0.09789078480720337,0.15865058227374337,0.10304293137600355,GABARAP,1
R-HSA-1632852,Macroautophagy,1/9,136/10899,0.10689596067893681,0.16747033839700098,0.10877132841014622,GABARAP,1
R-HSA-9612973,Autophagy,1/9,151/10899,0.11804001257423036,0.17896389003189764,0.1162363451494968,GABARAP,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1/9,182/10899,0.14068017919434528,0.19492525351370568,0.12660318817239563,PCGF2,1
R-HSA-72163,mRNA Splicing - Major Pathway,1/9,185/10899,0.1428435008158292,0.19492525351370568,0.12660318817239563,PUF60,1
R-HSA-2990846,SUMOylation,1/9,188/10899,0.14500198008534426,0.19492525351370568,0.12660318817239563,PCGF2,1
R-HSA-72172,mRNA Splicing,1/9,193/10899,0.1485887105118724,0.19492525351370568,0.12660318817239563,PUF60,1
R-HSA-9711123,Cellular response to chemical stress,1/9,194/10899,0.14930444949985966,0.19492525351370568,0.12660318817239563,TXN2,1
R-HSA-913531,Interferon Signaling,1/9,200/10899,0.15358766314146,0.1950978423688816,0.12671528395739232,TRIM8,1
R-HSA-416476,G alpha (q) signalling events,1/9,216/10899,0.16491599983577865,0.20213246532254,0.1312842439944829,ABHD6,1
R-HSA-5689880,Ub-specific processing proteases,1/9,220/10899,0.16772693931019278,0.20213246532254,0.1312842439944829,FOXO4,1
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,1/9,246/10899,0.18579394653762538,0.21830788718170982,0.1417901170945036,PUF60,1
R-HSA-76002,"Platelet activation, signaling and aggregation",1/9,263/10899,0.19741766854670784,0.22395626461326804,0.1454587160982032,ABHD6,1
R-HSA-1257604,PIP3 activates AKT signaling,1/9,267/10899,0.20013113007994165,0.22395626461326804,0.1454587160982032,FOXO4,1
R-HSA-5688426,Deubiquitination,1/9,298/10899,0.22088549193525797,0.24143297955714244,0.1568097739564867,FOXO4,1
R-HSA-9006925,Intracellular signaling by second messengers,1/9,309/10899,0.22813403895151174,0.24368863251638753,0.15827481171277133,FOXO4,1
R-HSA-195721,Signaling by WNT,1/9,332/10899,0.24309669799375555,0.2510131181550898,0.16303203642771788,CTBP2,1
R-HSA-73894,DNA Repair,1/9,336/10899,0.24567241351349212,0.2510131181550898,0.16303203642771788,ASCC1,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/9,374/10899,0.2697558841171659,0.2697558841171659,0.17520538946019734,TXN2,1
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,1/2,200/4383,0.08918945683776991,0.08918945683776991,0.08918945683776991,FOXO4,1
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,1/2,200/4383,0.08918945683776991,0.08918945683776991,0.08918945683776991,ABHD6,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,3/16,200/21728,3.938283982326142e-4,0.11617937747862118,0.07959479206385466,CCDC28B/PUF60/GABARAP,3
MUELLER_PLURINET,MUELLER_PLURINET,3/16,299/21728,0.0012649495008316043,0.12462141121285414,0.0853784512145156,SEPHS1/CTBP2/FOXO4,3
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,3/16,354/21728,0.0020511952250946994,0.12462141121285414,0.0853784512145156,TRIM8/FOXO4/ABHD6,3
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,3/16,467/21728,0.004484991651641968,0.12462141121285414,0.0853784512145156,PCGF2/ATPAF2/CCDC28B,3
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,3/16,474/21728,0.004675404600208071,0.12462141121285414,0.0853784512145156,GABARAP/ASCC1/ABHD6,3
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,2/16,166/21728,0.006489319345446128,0.12462141121285414,0.0853784512145156,CTBP2/RPRM,2
BIOCARTA_GABA_PATHWAY,BIOCARTA_GABA_PATHWAY,1/16,10/21728,0.007340932248729781,0.12462141121285414,0.0853784512145156,GABARAP,1
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,1/16,10/21728,0.007340932248729781,0.12462141121285414,0.0853784512145156,FOXO4,1
REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,1/16,10/21728,0.007340932248729781,0.12462141121285414,0.0853784512145156,FOXO4,1
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,1/16,12/21728,0.008803042942364114,0.12462141121285414,0.0853784512145156,FOXO4,1
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,1/16,12/21728,0.008803042942364114,0.12462141121285414,0.0853784512145156,PUF60,1
REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,1/16,12/21728,0.008803042942364114,0.12462141121285414,0.0853784512145156,FOXO4,1
FOSTER_KDM1A_TARGETS_DN,FOSTER_KDM1A_TARGETS_DN,2/16,202/21728,0.00947242624956452,0.12462141121285414,0.0853784512145156,CCDC28B/CTBP2,2
HO_LIVER_CANCER_VASCULAR_INVASION,HO_LIVER_CANCER_VASCULAR_INVASION,1/16,13/21728,0.009533340939828161,0.12462141121285414,0.0853784512145156,TRIM8,1
MALIK_REPRESSED_BY_ESTROGEN,MALIK_REPRESSED_BY_ESTROGEN,1/16,13/21728,0.009533340939828161,0.12462141121285414,0.0853784512145156,RPRM,1
WP_NEUROINFLAMMATION,WP_NEUROINFLAMMATION,1/16,13/21728,0.009533340939828161,0.12462141121285414,0.0853784512145156,ASCC1,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,2/16,207/21728,0.00992709442795003,0.12462141121285414,0.0853784512145156,TRIM8/ABHD6,2
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,2/16,209/21728,0.010111662109198389,0.12462141121285414,0.0853784512145156,SEPHS1/FAM89B,2
REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,1/16,14/21728,0.010263134471716562,0.12462141121285414,0.0853784512145156,TXN2,1
REACTOME_REPRESSION_OF_WNT_TARGET_GENES,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,1/16,14/21728,0.010263134471716562,0.12462141121285414,0.0853784512145156,CTBP2,1
WU_ALZHEIMER_DISEASE_UP,WU_ALZHEIMER_DISEASE_UP,1/16,14/21728,0.010263134471716562,0.12462141121285414,0.0853784512145156,FOXO4,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,1/16,16/21728,0.011721209439581215,0.12462141121285414,0.0853784512145156,FOXO4,1
REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,1/16,16/21728,0.011721209439581215,0.12462141121285414,0.0853784512145156,PCGF2,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/16,17/21728,0.012449491525477252,0.12462141121285414,0.0853784512145156,FOXO4,1
WIKMAN_ASBESTOS_LUNG_CANCER_UP,WIKMAN_ASBESTOS_LUNG_CANCER_UP,1/16,17/21728,0.012449491525477252,0.12462141121285414,0.0853784512145156,CTBP2,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,2/16,242/21728,0.013375662016117,0.12462141121285414,0.0853784512145156,SEPHS1/CCDC28B,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,2/16,250/21728,0.014227769718217669,0.12462141121285414,0.0853784512145156,FCHSD2/SEPHS1,2
TOMLINS_METASTASIS_DN,TOMLINS_METASTASIS_DN,1/16,20/21728,0.014631320086449406,0.12462141121285414,0.0853784512145156,CTBP2,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,2/16,265/21728,0.015887766336596013,0.12462141121285414,0.0853784512145156,FCHSD2/ABHD6,2
BIOCARTA_AKT_PATHWAY,BIOCARTA_AKT_PATHWAY,1/16,22/21728,0.016083360955476023,0.12462141121285414,0.0853784512145156,FOXO4,1
BIOCARTA_RAS_PATHWAY,BIOCARTA_RAS_PATHWAY,1/16,22/21728,0.016083360955476023,0.12462141121285414,0.0853784512145156,FOXO4,1
HASLINGER_B_CLL_WITH_17P13_DELETION,HASLINGER_B_CLL_WITH_17P13_DELETION,1/16,22/21728,0.016083360955476023,0.12462141121285414,0.0853784512145156,GABARAP,1
SAGIV_CD24_TARGETS_UP,SAGIV_CD24_TARGETS_UP,1/16,22/21728,0.016083360955476023,0.12462141121285414,0.0853784512145156,TRIM8,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,2/16,270/21728,0.0164589130425816,0.12462141121285414,0.0853784512145156,CTBP2/ABHD6,2
JIANG_TIP30_TARGETS_DN,JIANG_TIP30_TARGETS_DN,1/16,24/21728,0.01753339564306844,0.12462141121285414,0.0853784512145156,PCGF2,1
WANG_LSD1_TARGETS_UP,WANG_LSD1_TARGETS_UP,1/16,24/21728,0.01753339564306844,0.12462141121285414,0.0853784512145156,RPRM,1
DELACROIX_RAR_TARGETS_DN,DELACROIX_RAR_TARGETS_DN,1/16,25/21728,0.018257661477463882,0.12462141121285414,0.0853784512145156,CTBP2,1
KEGG_SELENOAMINO_ACID_METABOLISM,KEGG_SELENOAMINO_ACID_METABOLISM,1/16,26/21728,0.018981426736476514,0.12462141121285414,0.0853784512145156,SEPHS1,1
PETRETTO_HEART_MASS_QTL_CIS_DN,PETRETTO_HEART_MASS_QTL_CIS_DN,1/16,26/21728,0.018981426736476514,0.12462141121285414,0.0853784512145156,TXN2,1
PID_HDAC_CLASSIII_PATHWAY,PID_HDAC_CLASSIII_PATHWAY,1/16,26/21728,0.018981426736476514,0.12462141121285414,0.0853784512145156,FOXO4,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,1/16,26/21728,0.018981426736476514,0.12462141121285414,0.0853784512145156,FOXO4,1
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,1/16,26/21728,0.018981426736476514,0.12462141121285414,0.0853784512145156,CCDC28B,1
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,1/16,27/21728,0.019704691743029912,0.12462141121285414,0.0853784512145156,ABHD6,1
REACTOME_SULFUR_AMINO_ACID_METABOLISM,REACTOME_SULFUR_AMINO_ACID_METABOLISM,1/16,28/21728,0.020427456819851586,0.12462141121285414,0.0853784512145156,TXN2,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1/16,30/21728,0.0218714884742498,0.12462141121285414,0.0853784512145156,FOXO4,1
WP_PI3KAKTMTOR_SIGNALING_PATHWAY_AND_THERAPEUTIC_OPPORTUNITIES,WP_PI3KAKTMTOR_SIGNALING_PATHWAY_AND_THERAPEUTIC_OPPORTUNITIES,1/16,30/21728,0.0218714884742498,0.12462141121285414,0.0853784512145156,FOXO4,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,2/16,322/21728,0.022908763960553236,0.12462141121285414,0.0853784512145156,FCHSD2/CTBP2,2
FIRESTEIN_CTNNB1_PATHWAY,FIRESTEIN_CTNNB1_PATHWAY,1/16,32/21728,0.023313524277635334,0.12462141121285414,0.0853784512145156,FOXO4,1
MAYBURD_RESPONSE_TO_L663536_UP,MAYBURD_RESPONSE_TO_L663536_UP,1/16,32/21728,0.023313524277635334,0.12462141121285414,0.0853784512145156,TRIM8,1
REACTOME_SIGNALING_BY_WNT_IN_CANCER,REACTOME_SIGNALING_BY_WNT_IN_CANCER,1/16,34/21728,0.024753566804883498,0.12462141121285414,0.0853784512145156,CTBP2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,1/16,34/21728,0.024753566804883498,0.12462141121285414,0.0853784512145156,PCGF2,1
WP_OXIDATIVE_STRESS_RESPONSE,WP_OXIDATIVE_STRESS_RESPONSE,1/16,34/21728,0.024753566804883498,0.12462141121285414,0.0853784512145156,TXN2,1
JAZAG_TGFB1_SIGNALING_DN,JAZAG_TGFB1_SIGNALING_DN,1/16,35/21728,0.02547284139376149,0.12462141121285414,0.0853784512145156,PCGF2,1
KEGG_REGULATION_OF_AUTOPHAGY,KEGG_REGULATION_OF_AUTOPHAGY,1/16,35/21728,0.02547284139376149,0.12462141121285414,0.0853784512145156,GABARAP,1
PID_PI3KCI_AKT_PATHWAY,PID_PI3KCI_AKT_PATHWAY,1/16,35/21728,0.02547284139376149,0.12462141121285414,0.0853784512145156,FOXO4,1
YAGI_AML_RELAPSE_PROGNOSIS,YAGI_AML_RELAPSE_PROGNOSIS,1/16,35/21728,0.02547284139376149,0.12462141121285414,0.0853784512145156,GABARAP,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,2/16,341/21728,0.025489012109967006,0.12462141121285414,0.0853784512145156,FCHSD2/SEPHS1,2
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,2/16,342/21728,0.02562801191589102,0.12462141121285414,0.0853784512145156,SEPHS1/CTBP2,2
HOUSTIS_ROS,HOUSTIS_ROS,1/16,36/21728,0.026191618627786295,0.12462141121285414,0.0853784512145156,TXN2,1
MEDINA_SMARCA4_TARGETS,MEDINA_SMARCA4_TARGETS,1/16,36/21728,0.026191618627786295,0.12462141121285414,0.0853784512145156,ASCC1,1
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1/16,36/21728,0.026191618627786295,0.12462141121285414,0.0853784512145156,RPRM,1
WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,1/16,36/21728,0.026191618627786295,0.12462141121285414,0.0853784512145156,FOXO4,1
REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,1/16,37/21728,0.026909898827950585,0.12463963933907499,0.08539093935094522,TXN2,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,2/16,359/21728,0.028039023494352167,0.12463963933907499,0.08539093935094522,TRIM8/ABHD6,2
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,2/16,364/21728,0.028765204940858175,0.12463963933907499,0.08539093935094522,CCDC28B/GABARAP,2
ZHAN_MULTIPLE_MYELOMA_LB_DN,ZHAN_MULTIPLE_MYELOMA_LB_DN,1/16,40/21728,0.02906176043231601,0.12463963933907499,0.08539093935094522,SEPHS1,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,2/16,367/21728,0.02920458897318353,0.12463963933907499,0.08539093935094522,PCGF2/PUF60,2
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,1/16,43/21728,0.03120916026920495,0.12463963933907499,0.08539093935094522,PCGF2,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1/16,44/21728,0.03192397020398452,0.12463963933907499,0.08539093935094522,TRIM8,1
IKEDA_MIR133_TARGETS_UP,IKEDA_MIR133_TARGETS_UP,1/16,44/21728,0.03192397020398452,0.12463963933907499,0.08539093935094522,CTBP2,1
REACTOME_TBC_RABGAPS,REACTOME_TBC_RABGAPS,1/16,44/21728,0.03192397020398452,0.12463963933907499,0.08539093935094522,GABARAP,1
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,1/16,45/21728,0.0326382856659263,0.12463963933907499,0.08539093935094522,TRIM8,1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1/16,45/21728,0.0326382856659263,0.12463963933907499,0.08539093935094522,TRIM8,1
LUI_THYROID_CANCER_PAX8_PPARG_UP,LUI_THYROID_CANCER_PAX8_PPARG_UP,1/16,46/21728,0.03335210697429403,0.12463963933907499,0.08539093935094522,CTBP2,1
KEGG_NOTCH_SIGNALING_PATHWAY,KEGG_NOTCH_SIGNALING_PATHWAY,1/16,47/21728,0.03406543444816257,0.12463963933907499,0.08539093935094522,CTBP2,1
REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,1/16,47/21728,0.03406543444816257,0.12463963933907499,0.08539093935094522,PCGF2,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1/16,47/21728,0.03406543444816257,0.12463963933907499,0.08539093935094522,RPRM,1
WP_NOTCH_SIGNALING,WP_NOTCH_SIGNALING,1/16,47/21728,0.03406543444816257,0.12463963933907499,0.08539093935094522,CTBP2,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1/16,47/21728,0.03406543444816257,0.12463963933907499,0.08539093935094522,ABHD6,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,2/16,400/21728,0.0342159627634596,0.12463963933907499,0.08539093935094522,GABARAP/ASCC1,2
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,2/16,403/21728,0.03468741491063391,0.12463963933907499,0.08539093935094522,SEPHS1/CUEDC2,2
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,1/16,48/21728,0.03477826840641274,0.12463963933907499,0.08539093935094522,FOXO4,1
HENDRICKS_SMARCA4_TARGETS_DN,HENDRICKS_SMARCA4_TARGETS_DN,1/16,49/21728,0.03549060916773661,0.12463963933907499,0.08539093935094522,FCHSD2,1
PID_FOXO_PATHWAY,PID_FOXO_PATHWAY,1/16,49/21728,0.03549060916773661,0.12463963933907499,0.08539093935094522,FOXO4,1
ZHAN_MULTIPLE_MYELOMA_HP_UP,ZHAN_MULTIPLE_MYELOMA_HP_UP,1/16,50/21728,0.036202457050633075,0.12564382152866774,0.08607890716683034,FCHSD2,1
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,1/16,52/21728,0.03762467545418968,0.12747307342106215,0.08733213237054034,CTBP2,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/16,52/21728,0.03762467545418968,0.12747307342106215,0.08733213237054034,TRIM8,1
PEART_HDAC_PROLIFERATION_CLUSTER_UP,PEART_HDAC_PROLIFERATION_CLUSTER_UP,1/16,53/21728,0.03833504661089415,0.12747307342106215,0.08733213237054034,FAM89B,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,ROVERSI_GLIOMA_COPY_NUMBER_DN,1/16,54/21728,0.03904492616126187,0.12747307342106215,0.08733213237054034,CTBP2,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2/16,432/21728,0.03937662703449864,0.12747307342106215,0.08733213237054034,CTBP2/FOXO4,2
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,2/16,433/21728,0.039542512680479654,0.12747307342106215,0.08733213237054034,GABARAP/TRIM8,2
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,1/16,55/21728,0.03975431442283972,0.12747307342106215,0.08733213237054034,PCGF2,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,2/16,450/21728,0.04240423914432745,0.13450807040404944,0.09215182700295269,ATPAF2/TXN2,2
KAUFFMANN_MELANOMA_RELAPSE_UP,KAUFFMANN_MELANOMA_RELAPSE_UP,1/16,61/21728,0.04400034468627212,0.13808618811117312,0.09460320470060747,CTBP2,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,2/16,466/21728,0.045168235080927086,0.13881137629658144,0.09510003300247508,FCHSD2/CTBP2,2
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,1/16,63/21728,0.04541177216167491,0.13881137629658144,0.09510003300247508,ABHD6,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,2/16,470/21728,0.045869720320124055,0.13881137629658144,0.09510003300247508,FCHSD2/ABHD6,2
GOLDRATH_IMMUNE_MEMORY,GOLDRATH_IMMUNE_MEMORY,1/16,64/21728,0.04611675308230323,0.13881137629658144,0.09510003300247508,PCGF2,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/16,65/21728,0.046821245879140494,0.13881137629658144,0.09510003300247508,PCGF2,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1/16,66/21728,0.04752525086764314,0.13881137629658144,0.09510003300247508,FOXO4,1
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,1/16,66/21728,0.04752525086764314,0.13881137629658144,0.09510003300247508,FOXO4,1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,1/16,67/21728,0.048228768363078656,0.1394851634030216,0.09556164629216823,RPRM,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/16,68/21728,0.04893179868052422,0.14014447194907423,0.09601334028268421,RPRM,1
REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1/16,71/21728,0.05103796971286756,0.14477116408938395,0.09918309903715153,PCGF2,1
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/16,72/21728,0.05173905446535376,0.14536210540266056,0.09958795445962829,RPRM,1
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,1/16,73/21728,0.052439653612405435,0.145940545430751,0.09998424521928344,CTBP2,1
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,1/16,77/21728,0.055237200422339816,0.14655048388380806,0.10040211563136894,ABHD6,1
REACTOME_SENSORY_PROCESSING_OF_SOUND,REACTOME_SENSORY_PROCESSING_OF_SOUND,1/16,77/21728,0.055237200422339816,0.14655048388380806,0.10040211563136894,CTBP2,1
REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1/16,77/21728,0.055237200422339816,0.14655048388380806,0.10040211563136894,PCGF2,1
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,1/16,78/21728,0.05593537624762446,0.14655048388380806,0.10040211563136894,CTBP2,1
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,1/16,78/21728,0.05593537624762446,0.14655048388380806,0.10040211563136894,PCGF2,1
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1/16,78/21728,0.05593537624762446,0.14655048388380806,0.10040211563136894,RPRM,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,1/16,79/21728,0.05663306834831905,0.14655048388380806,0.10040211563136894,CTBP2,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,1/16,79/21728,0.05663306834831905,0.14655048388380806,0.10040211563136894,ASCC1,1
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,1/16,82/21728,0.05872324543007745,0.14825354273539407,0.10156888565636274,FOXO4,1
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1/16,82/21728,0.05872324543007745,0.14825354273539407,0.10156888565636274,TRIM8,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/16,83/21728,0.05941900575868864,0.14825354273539407,0.10156888565636274,FOXO4,1
BHATTACHARYA_EMBRYONIC_STEM_CELL,BHATTACHARYA_EMBRYONIC_STEM_CELL,1/16,84/21728,0.06011428392491014,0.14825354273539407,0.10156888565636274,SEPHS1,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/16,84/21728,0.06011428392491014,0.14825354273539407,0.10156888565636274,CTBP2,1
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1/16,85/21728,0.06080908024061926,0.14825354273539407,0.10156888565636274,CTBP2,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/16,85/21728,0.06080908024061926,0.14825354273539407,0.10156888565636274,RPRM,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/16,86/21728,0.06150339501750568,0.14871722565708342,0.10188655602554868,RPRM,1
LI_DCP2_BOUND_MRNA,LI_DCP2_BOUND_MRNA,1/16,89/21728,0.06358345322932157,0.15126708631169244,0.10363347215644943,CUEDC2,1
WNT_SIGNALING,WNT_SIGNALING,1/16,89/21728,0.06358345322932157,0.15126708631169244,0.10363347215644943,CTBP2,1
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/16,90/21728,0.0642758449640749,0.15169099411521675,0.1039238924892832,CTBP2,1
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,1/16,93/21728,0.06635014151134944,0.15534358528450862,0.10642629214853043,TRIM8,1
CROONQUIST_IL6_DEPRIVATION_DN,CROONQUIST_IL6_DEPRIVATION_DN,1/16,95/21728,0.06773061009872772,0.1573270077096431,0.10778513998305611,SEPHS1,1
BRUINS_UVC_RESPONSE_MIDDLE,BRUINS_UVC_RESPONSE_MIDDLE,1/16,99/21728,0.07048580856283904,0.1624477619221681,0.11129338194132478,RPRM,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/16,101/21728,0.07186054338928771,0.1633107977681303,0.11188465003204644,ASCC1,1
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,1/16,102/21728,0.07254719578239655,0.1633107977681303,0.11188465003204644,CTBP2,1
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,1/16,103/21728,0.07323337190685264,0.1633107977681303,0.11188465003204644,CTBP2,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/16,105/21728,0.07460429658296197,0.1633107977681303,0.11188465003204644,FOXO4,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/16,105/21728,0.07460429658296197,0.1633107977681303,0.11188465003204644,TRIM8,1
XU_GH1_EXOGENOUS_TARGETS_DN,XU_GH1_EXOGENOUS_TARGETS_DN,1/16,105/21728,0.07460429658296197,0.1633107977681303,0.11188465003204644,FOXO4,1
WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,1/16,106/21728,0.07528904575073125,0.1633107977681303,0.11188465003204644,ATPAF2,1
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,1/16,106/21728,0.07528904575073125,0.1633107977681303,0.11188465003204644,CTBP2,1
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,1/16,107/21728,0.07597331988207834,0.16359218514754095,0.11207742925362305,PCGF2,1
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,1/16,108/21728,0.07665711928459851,0.16386847963012002,0.11226671931840512,FAM89B,1
CHENG_IMPRINTED_BY_ESTRADIOL,CHENG_IMPRINTED_BY_ESTRADIOL,1/16,110/21728,0.07802329513261286,0.16440622902943425,0.11263513282302007,RPRM,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/16,110/21728,0.07802329513261286,0.16440622902943425,0.11263513282302007,CUEDC2,1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,1/16,111/21728,0.07870567219237179,0.16466789572162893,0.11281440135076808,SEPHS1,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/16,113/21728,0.08006900611767398,0.16634054087826639,0.11396033487467312,TXN2,1
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,1/16,114/21728,0.08074996359637465,0.16658209273377989,0.11412582267577426,CTBP2,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,1/16,115/21728,0.08143044849423997,0.16681932156806106,0.11428834876384555,SEPHS1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,1/16,116/21728,0.08211046111738751,0.1670523174457194,0.11444797484238403,SEPHS1,1
WP_WNT_SIGNALING,WP_WNT_SIGNALING,1/16,117/21728,0.08279000177175222,0.16728116796347195,0.11460476092412707,CTBP2,1
REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,1/16,120/21728,0.084825794978725,0.17022863618179504,0.11662407902552953,PCGF2,1
REACTOME_RAB_REGULATION_OF_TRAFFICKING,REACTOME_RAB_REGULATION_OF_TRAFFICKING,1/16,122/21728,0.08618063620663652,0.17177897081728224,0.11768621729498016,GABARAP,1
YAGI_AML_SURVIVAL,YAGI_AML_SURVIVAL,1/16,124/21728,0.08753359688620299,0.17330477235858982,0.11873154787814182,GABARAP,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,1/16,125/21728,0.08820937278186236,0.17347843313766265,0.11885052332714086,PCGF2,1
KEGG_SPLICEOSOME,KEGG_SPLICEOSOME,1/16,127/21728,0.08955951720633937,0.1738161682623034,0.11908190653474486,PUF60,1
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,1/16,127/21728,0.08955951720633937,0.1738161682623034,0.11908190653474486,SEPHS1,1
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1/16,130/21728,0.09158121998468216,0.17543155776286518,0.12018861406055348,PUF60,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1/16,130/21728,0.09158121998468216,0.17543155776286518,0.12018861406055348,CTBP2,1
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1/16,133/21728,0.09359871341707093,0.17813948682603822,0.12204382326708059,PCGF2,1
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,1/16,138/21728,0.09695187058238264,0.18333847321668512,0.12560566229296535,CUEDC2,1
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,1/16,139/21728,0.09762110495341958,0.18342819083604317,0.12566712806608488,ABHD6,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,1/16,140/21728,0.09828987434156822,0.18351590462507988,0.1257272210098674,CTBP2,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,1/16,145/21728,0.1016267570867273,0.1840021899791241,0.12606037636393158,CTBP2,1
KIM_ALL_DISORDERS_DURATION_CORR_DN,KIM_ALL_DISORDERS_DURATION_CORR_DN,1/16,145/21728,0.1016267570867273,0.1840021899791241,0.12606037636393158,PUF60,1
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,1/16,145/21728,0.1016267570867273,0.1840021899791241,0.12606037636393158,CTBP2,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,1/16,146/21728,0.10229274290364865,0.1840021899791241,0.12606037636393158,GABARAP,1
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,1/16,146/21728,0.10229274290364865,0.1840021899791241,0.12606037636393158,CTBP2,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,1/16,146/21728,0.10229274290364865,0.1840021899791241,0.12606037636393158,CTBP2,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/16,148/21728,0.10362332621012582,0.18435882711002174,0.12630470938492122,ABHD6,1
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1/16,150/21728,0.10495206041438698,0.18435882711002174,0.12630470938492122,PCGF2,1
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,1/16,151/21728,0.10561573485285991,0.18435882711002174,0.12630470938492122,CTBP2,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/16,151/21728,0.10561573485285991,0.18435882711002174,0.12630470938492122,CTBP2,1
REACTOME_AUTOPHAGY,REACTOME_AUTOPHAGY,1/16,151/21728,0.10561573485285991,0.18435882711002174,0.12630470938492122,GABARAP,1
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,1/16,152/21728,0.10627894791502568,0.1844252331466622,0.12635020433241442,GABARAP,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/16,155/21728,0.10826582183650801,0.185688473498662,0.12721565356554185,CTBP2,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,1/16,155/21728,0.10826582183650801,0.185688473498662,0.12721565356554185,CTBP2,1
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1/16,157/21728,0.10958810305298772,0.18686988670885188,0.12802504281213045,PUF60,1
REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1/16,160/21728,0.11156807875218411,0.1891527771947949,0.12958905698983272,TXN2,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/16,163/21728,0.1135439262543696,0.19033604350068845,0.13039971579708182,FOXO4,1
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,1/16,164/21728,0.11420162610041307,0.19033604350068845,0.13039971579708182,PCGF2,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/16,164/21728,0.11420162610041307,0.19033604350068845,0.13039971579708182,ATPAF2,1
FIRESTEIN_PROLIFERATION,FIRESTEIN_PROLIFERATION,1/16,166/21728,0.11551565359403071,0.1914444820799947,0.13115910993526844,FOXO4,1
DURAND_STROMA_NS_UP,DURAND_STROMA_NS_UP,1/16,167/21728,0.11617198183549682,0.19145661810877967,0.13116742435998463,ABHD6,1
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,1/16,171/21728,0.1187927316861348,0.19444521250827462,0.13321491811450037,PUF60,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,1/16,173/21728,0.12010037288891995,0.19444521250827462,0.13321491811450037,PUF60,1
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,1/16,175/21728,0.1214061947650471,0.19444521250827462,0.13321491811450037,SEPHS1,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1/16,175/21728,0.1214061947650471,0.19444521250827462,0.13321491811450037,ABHD6,1
VILLANUEVA_LIVER_CANCER_KRT19_UP,VILLANUEVA_LIVER_CANCER_KRT19_UP,1/16,175/21728,0.1214061947650471,0.19444521250827462,0.13321491811450037,CCDC28B,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1/16,179/21728,0.12401238998530673,0.19444521250827462,0.13321491811450037,CTBP2,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/16,179/21728,0.12401238998530673,0.19444521250827462,0.13321491811450037,PCGF2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1/16,179/21728,0.12401238998530673,0.19444521250827462,0.13321491811450037,CUEDC2,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/16,180/21728,0.1246628053994897,0.19444521250827462,0.13321491811450037,CTBP2,1
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,1/16,182/21728,0.125962278219939,0.19444521250827462,0.13321491811450037,PCGF2,1
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1/16,182/21728,0.125962278219939,0.19444521250827462,0.13321491811450037,FOXO4,1
WP_CILIOPATHIES,WP_CILIOPATHIES,1/16,184/21728,0.12725994232349236,0.19444521250827462,0.13321491811450037,CCDC28B,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,1/16,184/21728,0.12725994232349236,0.19444521250827462,0.13321491811450037,PUF60,1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,1/16,185/21728,0.12790809684089033,0.19444521250827462,0.13321491811450037,ATPAF2,1
WP_RAS_SIGNALING,WP_RAS_SIGNALING,1/16,185/21728,0.12790809684089033,0.19444521250827462,0.13321491811450037,FOXO4,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/16,187/21728,0.1292030522742933,0.19444521250827462,0.13321491811450037,ABHD6,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/16,187/21728,0.1292030522742933,0.19444521250827462,0.13321491811450037,PCGF2,1
REACTOME_MRNA_SPLICING,REACTOME_MRNA_SPLICING,1/16,188/21728,0.1298498537767122,0.19444521250827462,0.13321491811450037,PUF60,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/16,193/21728,0.13307711085835383,0.19720217084358121,0.1351037174022037,TRIM8,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/16,194/21728,0.13372121423547323,0.19720217084358121,0.1351037174022037,GABARAP,1
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,1/16,194/21728,0.13372121423547323,0.19720217084358121,0.1351037174022037,ABHD6,1
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,1/16,195/21728,0.13436486894766042,0.19720217084358121,0.1351037174022037,GABARAP,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,1/16,197/21728,0.1356508335438854,0.19797582784271942,0.13563375181374532,CTBP2,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1/16,199/21728,0.1369350069785651,0.19797582784271942,0.13563375181374532,ATPAF2,1
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,1/16,199/21728,0.1369350069785651,0.19797582784271942,0.13563375181374532,CTBP2,1
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1/16,200/21728,0.13757642273816095,0.19797582784271942,0.13563375181374532,ASCC1,1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1/16,202/21728,0.1388579137959981,0.1987528738226111,0.13616610802476833,TRIM8,1
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,1/16,203/21728,0.13949798967536542,0.1987528738226111,0.13616610802476833,TRIM8,1
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,1/16,204/21728,0.14013761950882409,0.1987528738226111,0.13616610802476833,CUEDC2,1
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,1/16,213/21728,0.14587426375682966,0.20247408624668028,0.13871552028318507,SEPHS1,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1/16,214/21728,0.14650944905917163,0.20247408624668028,0.13871552028318507,ABHD6,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1/16,215/21728,0.14714419149735414,0.20247408624668028,0.13871552028318507,PCGF2,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/16,216/21728,0.14777849135957866,0.20247408624668028,0.13871552028318507,PUF60,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/16,216/21728,0.14777849135957866,0.20247408624668028,0.13871552028318507,ABHD6,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/16,217/21728,0.14841234893387434,0.20247408624668028,0.13871552028318507,CTBP2,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,1/16,218/21728,0.14904576450809504,0.20247408624668028,0.13871552028318507,TXN2,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1/16,219/21728,0.1496787383699204,0.20247408624668028,0.13871552028318507,TRIM8,1
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1/16,219/21728,0.1496787383699204,0.20247408624668028,0.13871552028318507,FOXO4,1
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,1/16,219/21728,0.1496787383699204,0.20247408624668028,0.13871552028318507,CTBP2,1
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,1/16,220/21728,0.15031127080685758,0.20247408624668028,0.13871552028318507,ABHD6,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/16,224/21728,0.1528369920497672,0.20494051206673328,0.14040527499308755,CCDC28B,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1/16,227/21728,0.15472666208260144,0.20653558965777113,0.14149806677713492,FOXO4,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/16,236/21728,0.16037198994574153,0.21141565796721812,0.1448414142005562,SEPHS1,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/16,236/21728,0.16037198994574153,0.21141565796721812,0.1448414142005562,ABHD6,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,1/16,237/21728,0.16099706198002728,0.21141565796721812,0.1448414142005562,TXN2,1
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,1/16,238/21728,0.16162169773491653,0.21141565796721812,0.1448414142005562,GABARAP,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/16,239/21728,0.16224589749462992,0.21141565796721812,0.1448414142005562,RPRM,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/16,240/21728,0.16286966154321703,0.21141565796721812,0.1448414142005562,FCHSD2,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,1/16,241/21728,0.16349299016455476,0.21141565796721812,0.1448414142005562,TXN2,1
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1/16,242/21728,0.16411588364234897,0.21141565796721812,0.1448414142005562,PUF60,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1/16,247/21728,0.16722383379585215,0.21448274334685383,0.14694268232862065,ASCC1,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1/16,261/21728,0.17586855852243777,0.22459404659791835,0.1538699623436229,ABHD6,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1/16,265/21728,0.1783229839764603,0.22480889005579396,0.15401715215240833,FCHSD2,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/16,265/21728,0.1783229839764603,0.22480889005579396,0.15401715215240833,CTBP2,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/16,265/21728,0.1783229839764603,0.22480889005579396,0.15401715215240833,CCDC28B,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,1/16,268/21728,0.18015930403504365,0.22615742421420373,0.15494103639296025,TRIM8,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1/16,281/21728,0.1880723224816877,0.23509040310210963,0.16106104333846583,TXN2,1
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,1/16,284/21728,0.18988820702745235,0.2361148458510564,0.16176289171597796,CTBP2,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,1/16,285/21728,0.1904926552967845,0.2361148458510564,0.16176289171597796,PUF60,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,1/16,289/21728,0.1929062228431938,0.23686732414616343,0.16227841654259903,CTBP2,1
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,1/16,290/21728,0.19350855972618775,0.23686732414616343,0.16227841654259903,TXN2,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,1/16,290/21728,0.19350855972618775,0.23686732414616343,0.16227841654259903,SEPHS1,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,1/16,293/21728,0.19531304277368078,0.23808821329849517,0.16311485085927233,CTBP2,1
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,1/16,297/21728,0.19771313269823076,0.24002211582707025,0.16443977248455838,FOXO4,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,1/16,300/21728,0.19950879414467926,0.24120940275688682,0.1652531858316584,CTBP2,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/16,307/21728,0.2036840289142655,0.24525219808044216,0.1680229153664403,FOXO4,1
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1/16,311/21728,0.20606070188128545,0.246104886862264,0.16860709465675178,PUF60,1
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,1/16,311/21728,0.20606070188128545,0.246104886862264,0.16860709465675178,FCHSD2,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,1/16,314/21728,0.2078388407479136,0.24722765330901011,0.1693763048539873,FCHSD2,1
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,1/16,318/21728,0.2102038853667897,0.24903673165944964,0.1706157091119155,SEPHS1,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,1/16,323/21728,0.21315088251877168,0.2503574690259419,0.17152054969841515,PUF60,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,1/16,325/21728,0.21432679230304819,0.2503574690259419,0.17152054969841515,FCHSD2,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,1/16,325/21728,0.21432679230304819,0.2503574690259419,0.17152054969841515,CTBP2,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1/16,327/21728,0.21550105442431156,0.2503574690259419,0.17152054969841515,FCHSD2,1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,1/16,329/21728,0.21667367103752644,0.2503574690259419,0.17152054969841515,SEPHS1,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,1/16,329/21728,0.21667367103752644,0.2503574690259419,0.17152054969841515,CTBP2,1
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,1/16,330/21728,0.21725936295132586,0.2503574690259419,0.17152054969841515,ASCC1,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,1/16,335/21728,0.22018166933928063,0.25211420462627154,0.17272409380283366,CTBP2,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,1/16,336/21728,0.2207649018588228,0.25211420462627154,0.17272409380283366,RPRM,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,1/16,337/21728,0.2213477254176418,0.25211420462627154,0.17272409380283366,FOXO4,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1/16,339/21728,0.22251214672357533,0.25246570493636433,0.17296490757460106,CTBP2,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,1/16,341/21728,0.22367493539638483,0.25281266644418976,0.17320261180119334,CCDC28B,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,1/16,345/21728,0.22599562338685342,0.25446072098901434,0.17433169823333006,ATPAF2,1
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,1/16,359/21728,0.23406691666168722,0.26254654150265294,0.1798713147850468,PUF60,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,1/16,367/21728,0.23864358719309198,0.26666612962864444,0.18269365526743883,CTBP2,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/16,374/21728,0.24262713049496865,0.27009435281515376,0.18504233984124716,TXN2,1
BENPORATH_ES_1,BENPORATH_ES_1,1/16,379/21728,0.24546054621971236,0.27222128246171107,0.18649950484441935,SEPHS1,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,1/16,383/21728,0.24772012047937997,0.27369826045474566,0.18751138628835384,ABHD6,1
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,1/16,385/21728,0.2488475272362537,0.2739179870697569,0.18766192156072545,TRIM8,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1/16,399/21728,0.25669513476642114,0.2815058169371533,0.1928603634324119,RPRM,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1/16,408/21728,0.2616993659840421,0.2859307887603423,0.1958919230757742,TXN2,1
MOOTHA_PGC,MOOTHA_PGC,1/16,421/21728,0.2688719643048184,0.2911213212086608,0.19944797028389963,TXN2,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,1/16,421/21728,0.2688719643048184,0.2911213212086608,0.19944797028389963,RPRM,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,1/16,422/21728,0.2694209880327537,0.2911213212086608,0.19944797028389963,SEPHS1,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,1/16,425/21728,0.2710657410671067,0.2911213212086608,0.19944797028389963,SEPHS1,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1/16,428/21728,0.27270702220631604,0.2911213212086608,0.19944797028389963,PUF60,1
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,1/16,428/21728,0.27270702220631604,0.2911213212086608,0.19944797028389963,SEPHS1,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,1/16,430/21728,0.2737992841806912,0.2911213212086608,0.19944797028389963,ASCC1,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,1/16,431/21728,0.27434483829155154,0.2911213212086608,0.19944797028389963,TXN2,1
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,1/16,434/21728,0.2759791961514655,0.2918059600884671,0.1999170181515992,ABHD6,1
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,1/16,438/21728,0.27815297228228053,0.29305402436883127,0.20077207021878893,FOXO4,1
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,1/16,440/21728,0.2792375644474646,0.29314975627046996,0.20083765639225773,SEPHS1,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,1/16,445/21728,0.28194236461701316,0.29446022450464454,0.20173546156964045,ASCC1,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,1/16,446/21728,0.2824821814739471,0.29446022450464454,0.20173546156964045,CTBP2,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,1/16,451/21728,0.2851755636486738,0.2952581355207494,0.20228211247095051,TRIM8,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/16,452/21728,0.2857131014115927,0.2952581355207494,0.20228211247095051,CCDC28B,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1/16,453/21728,0.2862502601997774,0.2952581355207494,0.20228211247095051,RPRM,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,1/16,456/21728,0.28785946520900507,0.2954749279661677,0.20243063753614343,FAM89B,1
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,1/16,458/21728,0.28893037824279855,0.2954749279661677,0.20243063753614343,FCHSD2,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1/16,459/21728,0.2894652684143134,0.2954749279661677,0.20243063753614343,SEPHS1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1/16,463/21728,0.29160105926037594,0.2966286637303824,0.20322106489289357,TRIM8,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,1/16,467/21728,0.2937308302653806,0.29776836745115903,0.20400187886038368,PCGF2,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,1/16,484/21728,0.30271556558935575,0.30531063061332536,0.209169102864437,TXN2,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,1/16,485/21728,0.30324072803289603,0.30531063061332536,0.209169102864437,PCGF2,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,1/16,491/21728,0.30638392391674996,0.30742604610694296,0.21061837949164333,FCHSD2,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1/16,493/21728,0.3074286983900094,0.3074286983900094,0.21062019657763356,RPRM,1
